Acid-Neutralizing Capacity of Nonprescription Antacid Preparation Suspensions

Composition and Acid-Neutralizing Capacity of Nonprescription Antacid Preparation (Suspensions) 

Over 30% of patients with dementia develop a group of secondary behavioral disturbances, including depression, hallucinations and delusions, agitation, insomnia, and wandering. Because these secondary symptoms impair patients functions, increase their need for supervision, and often influence the decision to institutionalize them, the control of these symptoms is a priority in managing AD. 

Drugs used in the treatment of depression in Alzheimer s disease are  

Chlorpromazine Flaloperidol Thioridazine Atypical Antipsychotics Clozapine Risperidone Benzodiazepines Lorazepam Oxazepam Triazolam 

---